SCHEMBL6940159

SCHEMBL6940159

Cc1cn(CC[C@H](O)CO[Si](C)(C)C(C)(C)C)c2cc([N+](=O)[O-])ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 4/20 0.41
ADRB1 P08588 4/20 0.41
ADRB3 P13945 4/20 0.41
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
ASH1L Q9NR48 1/20 0.35
MAPT P10636 6/20 0.33
HTT P42858 3/20 0.33
ALDH1A1 P00352 3/20 0.33
GAA P10253 3/20 0.33
MAPK1 P28482 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TK1 P04183 1/20 0.33
POLB P06746 2/20 0.32
KMT2A Q03164 2/20 0.32
F2 P00734 1/20 0.32
PLAU P00749 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6940163 1.00 ADRB2 (0.41) ADRB2ADRB1ADRB3PDE4APDE4B
SCHEMBL6942605 0.82 HTR7 (0.45) ADRB2ADRB1ADRB3MAPT
SCHEMBL6942601 0.82 HTR7 (0.45) ADRB2ADRB1ADRB3MAPT
SCHEMBL6939003 0.81 ADA (0.41)
SCHEMBL6938174 0.80 TK1 (0.40) MAPTHTTALDH1A1GAATK1
SCHEMBL6938178 0.80 TK1 (0.40) MAPTHTTALDH1A1GAATK1
SCHEMBL6939007 0.72 ADA (0.36) PDE4APDE4BPDE4CPDE4DASH1L
SCHEMBL4724365 0.67 CNR2 (0.45) MAPTHTTALDH1A1GAAMAPK1
SCHEMBL4511606 0.66 HTR7 (0.51) MAPTHTTMAPK1POLBCYP1A2
SCHEMBL6933500 0.65 CDK4 (0.45) MAPTHTTALDH1A1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6596738-B1 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-22 US disclosed
EP-1161429-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP disclosed
WO-2000055155-A2 HETEROCYCLIC COMPOUNDS AS ADENOSINE DEAMINASE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-09-21 WO disclosed